Cardiff Oncology Gross Margin Growth & History (CRDF)

Cardiff Oncology's gross margin was 100.00% for fiscal 2019.

View full Cardiff Oncology company overview

Cardiff Oncology annual gross margin history

Cardiff Oncology annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20192019-12-31100.00%+157.92 pp
20182018-12-31−57.92%+200.49 pp
20172017-12-31−258.41%+95.71 pp
20162016-12-31−354.12%−252.98 pp
20152015-12-31−101.14%−195.63 pp
20142014-12-3194.49%

Cardiff Oncology gross margin trends

Over the last five fiscal years, Cardiff Oncology's gross margin increased from 94.49% to 100.00%, a change of +5.51 percentage points. The latest reported quarter, Q4 2019, shows 100.00%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardiff Oncology source filings ↗

Community posts

It’s quiet here.

No posts about CRDF yet. Start the conversation.

Write the first post